Chimeric antigen receptor-engineered natural killer cells for cancer immunotherapy
Ahmet Yılmaz(The Ohio State University Wexner Medical Center), Jianhua Yu(University of California, Irvine), Michael A. Caligiuri(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Hanwei Cui(Shenzhen Metro (China))
Cited by 172
Related Papers
MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response
|Proceedings of the National Academy of Sciences|2012|1.5k
Aberrant CpG-island methylation has non-random and tumour-type–specific patterns
|Nature Genetics|2000|1.4k
<i>IDH1</i> and <i>IDH2</i> Gene Mutations Identify Novel Molecular Subsets Within De Novo Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study
|Journal of Clinical Oncology|2010|764
Prevalence and Spectrum of Germline Cancer Susceptibility Gene Mutations Among Patients With Early-Onset Colorectal Cancer
|JAMA Oncology|2016|721
Evidence for discrete stages of human natural killer cell differentiation in vivo
|The Journal of Experimental Medicine|2006|429